Upon completion of the video presentation, to finish the activity and claim your credit, please click here.

This activity is supported by an unrestricted educational grant from Bristol-Myers Squibb, Lilly USA, LLC, and Merck & Co.

Collaborative Management of Patients with Gastric Cancer

David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center

Steve Malangone, MSN, FNP-C, AOCNP®
University of Arizona Cancer Center

Advanced gastric and esophageal cancers are associated with poor outcomes. However, as knowledge of disease biology improves, treatment options are increasing. Genomic profiling has identified targetable mutations or biomarkers, such as HER2. Immunotherapies such as checkpoint inhibitors may be approved for gastrointestinal malignancies in the very near future. This program provides an overview of clinical trials, new treatment options, as well as practical clinical information regarding diagnosis, staging, monitoring, and managing side effects to treatment, in order to ameliorate clinical confidence and patient outcomes.



 

Download Podcast

  
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

  





These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here